Endeavor

Cancer Survivor Paddles Missouri River With His Dog

Frank Carter and Amos completed a 64-day canoe trip after beating mantle cell lymphoma

What Are Bispecifics and How Do They Help Patients With Cancer?

A new class of immunotherapy is giving doctors another way to guide the immune system toward hard to treat cancers

Moffitt Continues Studying CAR T To Treat Ovarian Cancer

Targeting specific hormone receptor found on cancer cells may be key to success

Immunotherapy Pioneer Steven Rosenberg Reflects on Past Breakthroughs and Future Promise

Legendary researcher connects immunotherapy’s origins to its future at Moffitt

Many Lymphoma Patients Missing Out on Best Care

Study shows survival drops when CAR T therapy is not offered to eligible patients

Identifying Patients at Risk of Multiple Myeloma Relapse Can Improve Treatment Plans

Moffitt researchers lead national effort to refine risk-stratification tools to improve patient outcomes

Physician-Scientist Explores How AI Can Improve Treatment Decisions

Ciara Freeman, MD, PhD, and her colleagues are combining data in an AI platform to uncover patterns that clinicians can use to guide real-time decisions 

Can Hybrid Immunotherapy Improve Solid Tumor Treatment?

Moffitt researchers test CAR-TIL cells combining tumor navigation and targeted attack

Accelerating Impact Through Global Partnership

Moffitt is redefining the cancer treatment landscape through a series of groundbreaking international partnerships